Shares of Alembic Pharmaceuticals Ltd. rose to the highest level in over a month on Thursday after DSP Healthcare Fund raised its stake in the company.
With the acquisition of 36,276 shares, DSP Healthcare, a scheme launched by DSP Mutual Fund, now owns 5.01% voting rights compared to 4.99% earlier, according to an exchange filing.
Alembic Pharma's stock rose as much as 16.12% during the day on the NSE to Rs 835.40 apiece, the highest since Oct 19. It was trading 9.06% higher at Rs 784.55 apiece compared to a 0.1% decline in the benchmark Nifty 50 as of 11:12 a.m.
It has risen 36.77% on a year-to-date basis. The total traded volume so far in the day stood at 71 times its 30-day average. The relative strength index was at 62.24.
Eight out of 19 analysts tracking Alembic Pharma maintain a 'buy' rating on the stock, six recommend 'hold' and five suggest 'sell', according to Bloomberg data. The average of 12-month analyst price targets implies a potential downside of 2.6%.
RECOMMENDED FOR YOU
.png?rect=0%2C0%2C3500%2C1969&w=75)
Gujarat Gas Trims Morbi Industrial Gas Prices, Move Likely To Weigh On Q2 Margin
Jul 30, 2025
Why New DSP Global Equity Fund May Be Game Changer For Indian Middle Class — Expert Explains
Jul 24, 2025
GMDC Has Given The Highest Five-Session Returns In BSE PSU Index — Here's Why
Jul 22, 2025
Tata, Bosch To Jointly Produce Electronics, Semiconductors
Jul 17, 2025
POPULAR